Axsome Therapeutics
AXSM
$67.90
Share price
3.32%
Change (1 day)
-6.79%
Change (1 year)
Categories
Axsome Therapeutics (AXSM) - Cash on Hand
Cash on Hand as of December 2023 : $0.38 B
According to Axsome Therapeutics
's latest financial reports the company has $0.38 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Axsome Therapeutics - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.38 B | 92.29% |
| 2022-12-31 | $0.20 B | 132.26% |
| 2021-12-31 | $86.47 M | -52.97% |
| 2020-12-31 | $0.18 B | -16.41% |
| 2019-12-31 | $0.21 B | 1474.7% |
| 2018-12-31 | $13.96 M | -58.94% |
| 2017-12-31 | $34.02 M | -7.09% |
| 2016-12-31 | $36.61 M | -23.77% |
| 2015-12-31 | $48.03 M | 1734.98% |
| 2014-12-31 | $2.61 M | 25.38% |
| 2013-12-31 | $2.08 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -46.09% | 🇺🇸 USA |